153052-68-7

Basic information

• Product Name: L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-, (1R)-1-methyl-2-oxo-2-(phenylmethoxy)ethyl ester
• CAS NO: 153052-68-7
• Molecular Formula: C22H33NO6
• Molecular Weight: 407.507
• Mol File: 153052-68-7.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-, (1R)-1-methyl-2-oxo-2-(phenylmethoxy)ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-, (1R)-1-methyl-2-oxo-2-(phenylmethoxy)ethyl ester(153052-68-7)
• EPA Substance Registry System: L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-, (1R)-1-methyl-2-oxo-2-(phenylmethoxy)ethyl ester(153052-68-7)

Safety Data

• Hazardous Substances Data: 153052-68-7(Hazardous Substances Data)

Usage

General Description

L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-, (1R)-1-methyl-2-oxo-2-(phenylmethoxy)ethyl ester, also known as Boc-Leu-OH, is a chemical compound used in organic synthesis and peptide chemistry. It is a derivative of the amino acid leucine, with an added Boc (tert-butyloxycarbonyl) protecting group. The compound is commonly used as a building block for the synthesis of peptides and as a reagent in the production of pharmaceuticals and biochemicals. It is also used in the study and development of new drugs and biologically active compounds. It is important to handle this compound with caution due to its potential health hazards and environmental impact.

Upstream product

• 53363-89-6 N-t-butoxycarbonyl-N-methyl-L-leucine 
• 2051-96-9 benzyl (R)-Lactate 
• 13139-15-6 N-tert-butoxycarbonyl-L-leucine 
• 100-39-0 benzyl bromide 
• 2051-96-9 benzyl lactate 
• 56777-24-3 benzyl (S)-Lactate 

Relevant articles and documents

ENDOPARASITIC DEPSIPEPTIDES

The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof (1) wherein each of R1, R2, R3, R4, L1, and L2, are as defined herein. The present invention also contemplates compositions and methods of treatment as an endoparasiticide with a Formula (1) compound.

METHOD FOR THE SYNTHESIS OF CYCLIC DEPSIPEPTIDES

The present invention relates to a method for the synthesis of cyclic depsipeptides, in particular emodepside, from the open form.

ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS

The present invention provides cyclic depsipeptide compounds of formula (I) and compositions comprising the compounds that are effective against parasites that harm animals, including humans. The compounds and compositions may be used for combating parasites in or on animals including mammals and birds. The invention also provides for an improved method for eradicating, controlling and preventing parasite infestation in animals, including birds and mammals.